Merck and Moderna to start pivotal cancer vaccine trial

Merck and Moderna will begin their Phase III cancer vaccine trial in August, according to a federal clinical trials database.

The closely watched trial could help the duo win the first personalized cancer vaccine approval, though that is far down the line. The shot is given…
Click here to view original post